EDGAR Filing Documents for 0001140361-23-051010

Form 8-K - Current report:

SEC Accession No. 0001140361-23-051010

Filing Date

2023-11-02

Accepted

2023-11-02 08:45:20

Documents

Period of Report

2023-11-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ef20013909_8k.htm iXBRL	8-K	49916
2	EXHIBIT 4.1	ef20013909_ex4-1.htm	EX-4.1	1136667
3	EXHIBIT 10.1	ef20013909_ex10-1.htm	EX-10.1	294757
4	EXHIBIT 10.2	ef20013909_ex10-2.htm	EX-10.2	348826
5	EXHIBIT 10.3	ef20013909_ex10-3.htm	EX-10.3	118573
6	EXHIBIT 99.1	ef20013909_ex99-1.htm	EX-99.1	11072
10		image00001.jpg	GRAPHIC	2206
	Complete submission text file	0001140361-23-051010.txt		2488542

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	aqst-20231101.xsd	EX-101.SCH	3868
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	aqst-20231101_lab.xml	EX-101.LAB	23290
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	aqst-20231101_pre.xml	EX-101.PRE	16554
12	EXTRACTED XBRL INSTANCE DOCUMENT	ef20013909_8k_htm.xml	XML	4225

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059

Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900

Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)